Open surgical repair, while effective in preventing rupture of abdominal aortic aneurysms (AAA), is associated with significant morbidity and mortality. [1] [2] [3] The introduction of endovascular techniques now provides a less invasive alternative for the treatment of aneurysms. The clinical trials of the 2 FDAapproved devices demonstrated reduction in early morbidity compared to control patients undergoing open surgical repair. 4, 5 However, a number of reports have detailed complications following endovascular repair, raising questions regarding its overall suitability. [6] [7] [8] [9] [10] [11] Some investigators have emphasized that open surgical repair remains the standard and should be used preferentially in young, good risk patients. 12, 13 These reports, however, usually rely solely on the operative mortality rate and do not take into consideration the morbidity and graft complications associated with open surgical repair.
Previous reports have focused on the need for secondary procedures following endovascular AAA repair compared with open surgery. 10, 11 However, many of the studies comparing open versus endovascular repair have focused on technical success and 30-day mortalities. [13] [14] [15] Little is available in these comparative studies on the graft-related complications and secondary procedures that can occur following conventional surgical repair. In fact, several investigators using computed tomography (CT) surveillance have demonstrated graft-related sequelae in as many as 13% of conventionally treated patients within 3 years. [16] [17] [18] [19] [20] Morbidity and mortality associated with secondary procedures to treat these graft complications have ranged between 20% and 70%. [16] [17] [18] [19] [20] Furthermore, complications and outcome after endovascular repair may be device specific; many publications draw generalized conclusions based on a variety of devices.
The purpose of this study was to compare morbidity of open and endovascular aneurysm repair using a single stent-graft device and current reporting standards for endovascular AAA repair. 21 Both early (primary procedure) and late (any secondary procedures for graft-related complications) morbidity, as well as the need for secondary invasive procedures to treat the complications, were evaluated. Finally, the combined early and late morbidity, as well as hospital utilization, were considered.
METHODS
Between July 1993 and May 2000, 497 patients with infrarenal AAAs were treated at a single center and captured prospectively in a vascular database. There were 297 patients (255 men; mean age 73.4 Ϯ 8.1 years, range 50-93) who underwent open AAA repair (patients with ruptured aneurysm, emergent treatment, thoracoabdominal aneurysms, or suprarenal cross-clamping were excluded from this analysis). Of these, 276 patients had their primary repairs at our center, 20 had their primary and secondary procedures at our center, and 21 had their primary repairs elsewhere and secondary procedure at our facility.
Since beginning endovascular AAA repair in 1996, 200 patients (166 men; mean age 73.6 Ϯ 8.0 years, range 45-96) have been treated with a stent-graft, all but one at our facility (primary procedure elsewhere but secondary procedure here). One endograft patient treated initially at our facility had a secondary procedure elsewhere.
Of the 141 open procedures performed between 1996 and May 2000, 70 (49.6%) patients were endovascular candidates who elected conventional treatment (43 tube graft reconstructions and 27 aortoiliac grafts; in 12%, the inferior mesenteric artery was reimplanted). The other 71 surgically treated patients in this time period were considered poor candidates for endovascular repair for a variety of reasons: 26 required aortofemoral reconstructions, 16 had severe (Ͼ60Њ) proximal neck angulation, 15 had inadequate (Ͻ10 mm) proximal aortic necks, and 14 had a proximal neck diameter considered too large (Ͼ26 mm) for the device.
The patient groups were similar with regard to age, gender, and aneurysm size (63.7 Ϯ 1.5 mm [range in the open patients versus 57.6 Ϯ 9.4 mm [range 40-87] in the endograft group). The prevalence of comorbid factors (Table 1 ) was higher in the endovascular group, but the differences were not statistically significant.
Repair Procedures
Open repairs were performed under general anesthesia and were approached via either the transperitoneal (166, 55.8%) or retroperitoneal (131, 43.8%) route, based on Endovascular repair was performed under general anesthesia in 187 (93.5%) patients and epidural anesthesia in 13 (6.5%). Bilateral transverse groin incisions were used to expose both common femoral arteries in 180 (90.0%), while retroperitoneal exposure for external or common iliac artery access was used in 10 (5.0%) cases and percutaneous access and closure in the other 10 (5.0%). Femoral artery reconstructions were required in 32 (16.0%) patients. The internal iliac arteries were embolized or ligated in 4 (2.0%), and the internal iliac arteries were revascularized in 4 (2.0%).
Postoperative surveillance after open surgery consisted of clinical follow-up at 1, 6, and 12 months and then yearly thereafter. CT angiography, duplex ultrasound, or aortography was performed when there was clinical suspicion of a graft-related complication. Patients who received endografts were scheduled for routine clinical follow-up with abdominal radiograms, duplex ultrasound, and/or CT angiography at 1, 3, 6, and 12 months and then yearly thereafter.
Definitions and Statistical Analysis
Morbidity following all primary and secondary surgical and endovascular aneurysm repairs were recorded. Early major morbidity was the appearance of systemic complications (cardiac, pulmonary, renal, cerebrovascular, deep vein thrombosis [DVT], pulmonary embolism [PE], coagulopathy, bowel ischemia, and spinal cord ischemia) within 30 days of the primary procedure or during the same hospitalization, as defined by the reporting standards for endovascular aortic aneurysm repair. 21 Graft-related complications (e.g., pseudoaneurysms, graft infections, aortoenteric fistulas, graft thrombosis, placement of proximal or distal extender cuffs to secure fixation, and surgical conversions) occurring 30 days after the original operation and requiring a separate hospital admission were considered a secondary surgical procedure. Late percutaneous interventional procedures (e.g., arteriograms) were not considered in the analysis of secondary procedures.
Late major morbidity was the appearance of organ system complications (cardiac, pulmonary, renal, hematologic, cerebrovascular, and peripheral) within 30 days of a secondary procedure. All procedures performed as a result of morbidities following the primary and secondary procedures were recorded for each group. Finally, the combined early and late morbidities, as well as hospital stays, were compared.
Results are reported as the mean Ϯ standard deviation. Continuous variables were analyzed with the Student t test. Discrete variables were evaluated using the Fisher exact test. PϽ0.05 indicates statistical significance. Congestive heart failure Myocardial infarction Arrhythmia 
RESULTS
There were 11 (2.2%) deaths among all 497 AAA patients within 30 days after a primary procedure: 10 (3.4%) in the 297-patient surgery group and 1 (0.5%) among 200 endovascular repairs (pϽ0.05). The causes of death following open surgery were cardiac arrest (nϭ3), respiratory failure (nϭ3), multisystem organ failure (nϭ3), and a stroke. In the endovascular group, a 45-year-old man with no cardiac symptoms and a negative noninvasive preoperative cardiac evaluation suffered a myocardial infarction (MI) 3 weeks after an uneventful stent-graft procedure. He died during interventional efforts to treat a 95% left main coronary stenosis.
In the 297-patient surgical group, there were 36 (12.1%) early (30-day) major systemic complications after the primary procedure, while in the endograft cohort, there were 15 (7.5%, pϭNS) ( Table 2) . In the open group, the cardiac complications included 5 patients with congestive heart failure who required aggressive diuresis, 5 with dysrhythmias, and 5 with MI diagnosed by electrocardiography (ECG) and cardiac enzyme criteria. Pulmonary complications included 5 cases of pneumonias confirmed by chest radiograms and sputum cultures that were treated with intravenous antibiotics and 1 DVT with PE documented by duplex ultrasound and CT angiography (treated with intravenous heparin). There were 5 cases of postoperative bleeding and 5 patients with ischemic lower extremities after surgery. Four patients developed acute tubular necrosis (serum creatinine Ͼ3 mg/dL), and one suffered a disabling stroke after surgery.
Following endovascular repair, cardiac complications included 8 dysrhythmias, a case of congestive heart failure requiring aggressive diuresis, and an MI confirmed by ECG and cardiac enzymes. The cerebrovascular events included a transient ischemic attack that resolved within 4 hours and a subdural hematoma that was managed with conservative treatment. One patient had contrast-induced nephropathy (serum creatinine elevation from 1.8 to 3.1 mg/dL) but required no treatment.
Mean length of follow-up for open patients was 20.1 Ϯ 17.1 months (range 1-150) compared to 12.4 Ϯ 9.6 months (range 1-60) after endovascular repair (pϽ0.05). Late secondary procedures for graft-related complications (Table 3) were required in 32 (10.8%) patients treated with open surgery and in 30 (15.0%) endovascular patients (pϭNS). The major morbidity (Table 4) following the 32 secondary procedures for graft-related complications in the open surgery group was 21.9% (nϭ7); there were no major complications following the 30 secondary endovascular procedures (pϽ0.01).
Among the late percutaneous procedures not included in this analysis, there were 12 open surgery patients who underwent arteriography; one had balloon angioplasty and stenting of a kinked aortoiliac graft. Following endovascular aneurysm repair, 10 patients had arteriograms, and 6 had coil embolization for type II endoleaks. There were no complications related to these interventions in either group.
There were 43 (14.5%) combined primary and secondary morbidities (Table 5) in the open surgery group versus 15 (7.5%) for patients undergoing endovascular repair (pϽ0.01). The need for invasive procedures to treat these primary and secondary systemic 
DISCUSSION
The primary objective of AAA repair is to prevent rupture, but it should be accomplished while minimizing treatment-related morbidity and mortality and preserving functional outcome. Over the last 10 years, there has been a steady increase in the use of endoluminal devices to treat infrarenal aneurysms. [22] [23] [24] However, enthusiasm for endovascular grafts continues to fluctuate, with continued reports of aneurysm ruptures, stent fractures, endoleaks, and graft migration with long-term follow-up. [6] [7] [8] [9] [10] [11] The durability of endovascular grafts is questioned, and open surgery remains the ''gold standard.'' 12 Aneurysm repair is mainly performed in asymptomatic patients typically older than 70 years, with multiple medical comorbidities and shorter life expectancies than age- matched controls without aneurysms. The benefit of such a prophylactic procedure is often difficult to assess by technical variables alone. Endovascular AAA repair is associated with less surgical trauma, shorter hospitalization, and faster recovery than are the conventional open procedures. In clinical trials, endovascular and open aneurysm repair are often associated with similar morbidity and mortality. 4, 5 However, there is no data comparing the early and late morbidities after the primary and all secondary surgical procedures.
In this study, the patient groups were well matched with regard to preoperative demographics, although the incidence of each comorbid disease was higher in the endovascular group. This most likely represents a physiological selection bias to perform endovascular repair in patients with more comorbidities. Even with this bias, the rates of 30-day major systemic morbidity were not significantly different between the groups, though adverse events were more numerous following open aneurysm repairs.
The major complication for both groups was cardiac in nature, which is often unavoidable because patients with aneurysms usually have significant coronary pathology. However, postprocedural myocardial ischemia, dysrhythmias, and congestive heart failure can be effectively treated, oftentimes with medical therapy alone, as we did in the majority of cardiac complications after open (13 of 15) and endovascular (9 of 10) repairs.
The major types of systemic sequelae that were nonexistent in the endovascular cohort included pulmonary and bleeding complications, which accounted for 30% of the morbidities after open surgery. These complications are significant; they can be life threatening, prolong hospitalization, increase costs, necessitate skilled nursing care following discharge, and limit functional outcome after aneurysm repair. Furthermore, these 11 complications accounted for 50% of the nongraft-related invasive procedures in followup.
Regarding functional outcome, 7 (1.4%) of 497 patients had lower extremity limb ischemia immediately following repair. Four of the 5 open surgery patients required lower extremity amputations as a result of this complication, severely limiting their functional outcome, while the 2 endograft patients with limb ischemia were revascularized.
Long-term surveillance of prosthetic vascular grafts after open repair is not performed to the same standards as endovascular repair. In a few studies incorporating routine graft surveillance following open surgery, graft-related complications requiring treatment were noted in 10% to 14% of patients with as little as 3.5 years of follow-up. [16] [17] [18] [19] [20] On the other hand, the incidence of secondary procedures for endograft-related complications has been reported by a number of investigators. The EUROSTAR collaborators, for example, recorded an 18% rate of secondary interventions at a mean 14 months after endografting, leading them to suggest caution in the broad applicability of endovascular grafts. However, 75% of the devices represented in their registry are no longer available because of defined failure modes. 10, 11 In our own series of 497 AAAs, secondary interventions for graft-related complications were required at similar rates for both open and endovascular repairs. However, the major morbidity after these secondary procedures differed significantly, with no major complications after secondary procedures in the endovascular group versus 21.9% in the open cohort. Though the 22% late morbidity seems high, it is a considerable improvement over the 73% rate reported by Allen et al. 16 for treatment of graft-related complications following open surgery.
Based on combined early and late systemic morbidity of open and endovascular repair, there was a 50% reduction in major morbidity after endovascular procedures compared to open surgery with midterm follow-up. Furthermore, there was a fourfold reduction in the number of invasive procedures required to treat the complications following primary and secondary surgical procedures related to graft complications. These are not inconsequential, as 30% to 60% of AAA patients will expire within 10 years after aneurysm repair. 14, [25] [26] [27] There are several weaknesses with this study. First, follow-up between patients is not equivalent, which means that proportionally more events could occur in the endovascular cohort with additional time. Since only the cumulative total complications are reported, this difference in follow-up could have an impact on the results. The study considered a group of patients from 1993 through 1996, when endovascular repair was not offered. However, beginning in 1996, both open and endovascular repair were available to those who were anatomically suitable. Patients who were not anatomical candidates underwent open repair, which introduces a potential selection bias based on anatomical considerations, with more complex aneurysms being selected for open repair. However, it is not known if this increased morphological complexity entails a greater operative risk when all patients were treated with an infrarenal cross-clamp. Furthermore, with time, more complex aneurysm morphology was treated with endovascular techniques by either reconstructing iliac bifurcations or embolizing internal iliac arteries and bringing the endograft into the external iliac arteries to improve distal fixation. At the same time, patients with multiple comorbidities who were not candidates for open repair were selected for endovascular repair, presenting a potential bias against endovascular repair.
In conclusion, complications occur following both open and endovascular aneurysm repair, and both require secondary surgical procedures. However, endoluminal stentgrafts have significantly reduced the combined (early and late) systemic morbidity compared to open aneurysm surgery. Invasive procedures needed to treat these morbidities are reduced fourfold in endograft patients.
